Literature DB >> 1505748

The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, or pain.

G R Smith1.   

Abstract

This article reviews the relationship between depressive disorders and somatoform disorders, somatization, and pain. These disorders and symptoms are clinically interrelated, yet the nature of the interrelation is not well understood. This review of the literature from 1975 through mid-year 1990 addresses the epidemiology and treatment of these conditions and/or symptoms when they occur together. When robust criteria are used to determine which publications are included, only 14 are available that address depressive disorders, somatoform disorders, and somatization. Similarly, there are only 13 that address depressive disorders and pain. Taken together, these studies indicate that 1) in somatization disorder patients, there is a high prevalence of depression; 2) in patients with major depression, there are substantial levels of hypochondriacal and somatizing symptoms; 3) that depression in the face of coexisting somatization disorder can be successfully treated; 4) in chronic pain patients, there is a high prevalence of depressive disorders; 5) in patients with major depression, pain is a frequent complaint; 6) and finally, that pain improves with the treatment of depression. What is most striking from this review, however, is the very limited number of studies that address these important problems. This lack of research-based data calls for new aggressive research efforts in this area.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505748     DOI: 10.1016/0163-8343(92)90097-t

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  25 in total

1.  Treatment of fibromyalgia with antidepressants: a meta-analysis.

Authors:  P G O'Malley; E Balden; G Tomkins; J Santoro; K Kroenke; J L Jackson
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

Review 2.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

3.  The treatment of patients with medically unexplained symptoms in primary care: a review of the literature.

Authors:  Todd M Edwards; Anthony Stern; David D Clarke; Gabriel Ivbijaro; L Michelle Kasney
Journal:  Ment Health Fam Med       Date:  2010-12

4.  Sleep quality and presleep arousal in chronic pain.

Authors:  M T Smith; M L Perlis; M S Smith; D E Giles; T P Carmody
Journal:  J Behav Med       Date:  2000-02

5.  Echinocystic acid reduces reserpine-induced pain/depression dyad in mice.

Authors:  Shuo Li; Jing Han; Dong-Sheng Wang; Bin Feng; Ya-Ting Deng; Xin-Shang Wang; Qi Yang; Ming-Gao Zhao
Journal:  Metab Brain Dis       Date:  2016-01-04       Impact factor: 3.584

6.  Retrospective review of outcomes of a multimodal chronic pain service in a major teaching hospital: a preliminary experience in universiti sains malaysia.

Authors:  Nizar Abdul Jalil; Zaharah Sulaiman; Mohamed Saufi Awang; Mohamarowi Omar
Journal:  Malays J Med Sci       Date:  2009-10

7.  Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice.

Authors:  Shui-bing Liu; Rong Zhao; Xu-sheng Li; Hong-ju Guo; Zhen Tian; Nan Zhang; Guo-dong Gao; Ming-gao Zhao
Journal:  Neuromolecular Med       Date:  2014-03-01       Impact factor: 3.843

Review 8.  Management of insomnia in patients with chronic pain conditions.

Authors:  Frederic Stiefel; Daniele Stagno
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Somatization in frequent attenders of general practice.

Authors:  P J Portegijs; F G van der Horst; I M Proot; H F Kraan; N C Gunther; J A Knottnerus
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1996-01       Impact factor: 4.328

Review 10.  Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment.

Authors:  Carol S North; Barry A Hong; David H Alpers
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.